Ekpenyong, O.; Cooper, C.; Ma, J.; Guy, N.C.; Payan, A.N.; Ban, F.; Cherkasov, A.; Cox, M.B.; Liang, D.; Xie, H.
Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer. Pharmaceuticals 2020, 13, 386.
https://doi.org/10.3390/ph13110386
AMA Style
Ekpenyong O, Cooper C, Ma J, Guy NC, Payan AN, Ban F, Cherkasov A, Cox MB, Liang D, Xie H.
Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer. Pharmaceuticals. 2020; 13(11):386.
https://doi.org/10.3390/ph13110386
Chicago/Turabian Style
Ekpenyong, Oscar, Candace Cooper, Jing Ma, Naihsuan C. Guy, Ashley N. Payan, Fuqiang Ban, Artem Cherkasov, Marc B. Cox, Dong Liang, and Huan Xie.
2020. "Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer" Pharmaceuticals 13, no. 11: 386.
https://doi.org/10.3390/ph13110386
APA Style
Ekpenyong, O., Cooper, C., Ma, J., Guy, N. C., Payan, A. N., Ban, F., Cherkasov, A., Cox, M. B., Liang, D., & Xie, H.
(2020). Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer. Pharmaceuticals, 13(11), 386.
https://doi.org/10.3390/ph13110386
